Remedy Analytics, a data analytics company committed to providing unrivaled clarity and optimized savings to pharmacy benefits, has made significant strides since its founding in 2013. Named on the 2020 Inc. 5000 Annual List of America’s Fastest-Growing Private Companies, Remedy's mission is to revolutionize the management of pharmacy benefits. The company's services cater to plan sponsors of all sizes, offering data analytics and clinical intelligence to optimize pharmacy benefits, reduce spending, and manage population health. Remedy offers full-service Rx consulting, supported by PharmaLogic®, its proprietary claims analytics platform, and a team of experienced professionals ranging from clinicians, actuaries, and data scientists to PBM-savvy experts. As an analytics focused company operating in the healthcare industry, Remedy Analytics presents an opportunity for investors looking to tap into the growing demand for data-driven solutions in the healthcare and pharmaceutical sectors. With its track record of rapid expansion and commitment to innovation, Remedy Analytics could prove to be an appealing investment prospect for venture capitalists seeking exposure to the intersection of data analytics and healthcare.
There is no investment information
No recent news or press coverage available for Remedy Analytics.